According to a recent phase 2/3 study published in Nature Medicine on June 30, 2026, digital AVATAR therapy has shown promise in treating distressing voices in psychosis.[2218613] Meanwhile, a phase 1 trial of tumor-associated antigen-specific T cells found treatment to be generally well-tolerated with one complete response and three long-term responders in pediatric central nervous system tumors.[2218614] Additionally, a phase 1 trial of SEZ6-targeting antibody-drug conjugate ABBV-706 reported promising results in advanced small cell lung cancer and solid tumors.[2148748]